|
| Status |
Public on Mar 16, 2023 |
| Title |
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia. |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
36739349 |
| |
| Submission date |
Jan 04, 2023 |
| Last update date |
Mar 17, 2023 |
| Contact name |
Jerome Tamburini |
| E-mail(s) |
jerome.tamburinibonnefoy@unige.ch
|
| Organization name |
Cochin Institute
|
| Lab |
jerome tamburini
|
| Street address |
22 rue mechain
|
| City |
paris |
| State/province |
N/A |
| ZIP/Postal code |
75014 |
| Country |
France |
| |
|
| Platforms (1) |
| GPL23159 |
[Clariom_S_Human] Affymetrix Clariom S Assay, Human (Includes Pico Assay) |
|
| Samples (42)
|
| GSM6916956 |
AML cells_shCTL_72h_rep1 [MOLM-14 shCTL 1 ] |
| GSM6916957 |
AML cells_shCTL_72h_rep2 [MOLM-14 shCTL 2] |
| GSM6916958 |
AML cells_shCTL_72h_rep3 [MOLM-14 shCTL 3] |
|
| This SuperSeries is composed of the following SubSeries:
|
| GSE222165 |
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia [Cell lines shCTL shMFN2] |
| GSE222166 |
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia [PDX MFN2 OE] |
| GSE222167 |
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia [PDX shMFN2] |
| GSE222168 |
Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia [PDX shOPA1] |
|
| Relations |
| BioProject |
PRJNA918400 |
Less...
More...